COA5 (Cytochrome C Oxidase Assembly Factor 5)

📖 Wiki Page

gene1401 wordssynced 2026-04-02

COA5 (Cytochrome C Oxidase Assembly Factor 5)

Introduction

COA5 (Cytochrome C Oxidase Assembly Factor 5), also known as C15orf16 or PET191, is a mitochondrial protein that plays a critical role in the assembly and stabilization of Cytochrome c oxidase (Complex IV) within the mitochondrial electron transport chain. This nuclear-encoded protein is essential for proper mitochondrial function, and mutations in COA5 have been linked to mitochondrial encephalopathies and disorders characterized by impaired cellular energy metabolism.

Mitochondrial dysfunction is a hallmark of many neurodegenerative diseases, including [Parkinson's disease](/diseases/parkinsons-disease), [Alzheimer's disease](/diseases/alzheimers-disease), and [Amyotrophic Lateral Sclerosis (ALS)](/diseases/als). The role of COA5 in mitochondrial complex IV assembly places it at the intersection of fundamental cellular energy metabolism and neurodegenerative disease pathogenesis. Understanding COA5 function provides insight into how mitochondrial assembly defects contribute to neuronal dysfunction and death.

...

COA5 (Cytochrome C Oxidase Assembly Factor 5)

Introduction

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">COA5 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>COA5</td></tr>
<tr><td><strong>Full Name</strong></td><td>Cytochrome C Oxidase Assembly Factor 5</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>C15orf16, PET191</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>2p31.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>51168</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000163788</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q8N5L4</td></tr>
<tr><td><strong>OMIM</strong></td><td>614156</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Mitochondrial Complex IV Deficiency](/diseases/mitochondrial-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), Mitochondrial Encephalopathy</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The COA5 gene is located on chromosome 2p31.1 and encodes a protein involved in mitochondrial complex IV assembly. The gene structure and regulatory elements have been characterized through comparative genomics and functional studies.

Protein Structure

Cytochrome C Oxidase Assembly Factor 5 is a mitochondrial protein localized to the inner mitochondrial membrane. The protein contains domains necessary for interaction with other assembly factors and COX subunits:

| Feature | Description |
|--------|-------------|
| Mitochondrial targeting | N-terminal targeting sequence for import |
| Interaction domains | Regions for binding to other assembly factors |
| Conserved regions | Essential for assembly function |

The protein functions as part of a larger assembly complex that coordinates the integration of COX subunits and the addition of necessary cofactors (heme, copper).

Function

Normal Cellular Function

COA5 is essential for the proper assembly of Cytochrome c oxidase (Complex IV), the final enzyme in the mitochondrial electron transport chain. This complex catalyzes the transfer of electrons from cytochrome c to molecular oxygen, coupled with proton pumping across the inner mitochondrial membrane.

Mitochondrial Complex IV Assembly

Mermaid diagram (expand to render)

Role in Electron Transport Chain

Complex IV is the fourth of five complexes in the mitochondrial electron transport chain:

| Complex | Function | COA5 Relevance |
|---------|----------|----------------|
| Complex I (NADH dehydrogenase) | Electron input from NADH | Indirect |
| Complex II (Succinate dehydrogenase) | Electron input from FADH₂ | Indirect |
| Complex III (Cytochrome bc1) | Electron transfer | Indirect |
| Complex IV (Cytochrome c oxidase) | Final electron transfer | Direct - assembly |
| Complex V (ATP synthase) | ATP synthesis | Dependent on Complex IV |

Expression Pattern

COA5 is expressed in tissues with high energy demands:

| Tissue | Expression Level | Significance |
|--------|-----------------|--------------|
| [Brain](/brain-regions/brain) | High | Neuronal energy requirements |
| [Heart](/organs/heart) | High | Continuous contractile function |
| Skeletal Muscle | High | Metabolic activity |
| Liver | Moderate | Metabolic function |
| Kidney | Moderate | Energy-intensive transport |

Within the brain, COA5 is expressed in various neuronal populations, with particularly high expression in regions with high metabolic activity and vulnerability to neurodegeneration.

Disease Associations

Mitochondrial Complex IV Deficiency

COA5 mutations cause mitochondrial complex IV deficiency, leading to:

| Phenotype | Description |
|-----------|-------------|
| Encephalopathy | Severe neurological dysfunction |
| Lactic Acidosis | Elevated lactate due to impaired oxidative phosphorylation |
| Cardiomyopathy | Cardiac muscle involvement |
| Myopathy | Skeletal muscle weakness |

Parkinson's Disease

Mitochondrial dysfunction, particularly involving complex I and complex IV, is a central pathogenic mechanism in [Parkinson's disease](/diseases/parkinsons-disease):

Complex IV activity is reduced in PD substantia nigra

COA5 expression may be altered in dopaminergic neurons

Assembly factors provide therapeutic targets for neuroprotection

Energy deficit contributes to neuronal vulnerability

The substantia nigra pars compacta (SNc) dopaminergic neurons have particularly high energy requirements and are especially vulnerable to mitochondrial dysfunction. COA5 and other assembly factors represent potential therapeutic targets for supporting mitochondrial function in PD.

Alzheimer's Disease

Mitochondrial dysfunction is also prominent in [Alzheimer's disease](/diseases/alzheimers-disease):

Reduced complex IV activity in AD brain
Impaired cytochrome c oxidase function
Energy metabolism deficits
Relationship to amyloid and tau pathology

Amyotrophic Lateral Sclerosis (ALS)

COA5 and complex IV dysfunction have been implicated in [ALS](/diseases/als):

Mitochondrial respiratory defects in motor neurons
Energy failure contributing to motor neuron death
Interactions with other disease mechanisms

Broader Neurodegenerative Context

COA5 dysfunction contributes to neurodegenerative processes through:

ATP depletion — Impaired oxidative phosphorylation reduces cellular energy

Increased reactive oxygen species (ROS) — Electron leakage from damaged complexes

Apoptotic triggering — Mitochondrial dysfunction activates apoptotic pathways

Calcium dysregulation — Mitochondrial calcium buffering impaired

Mechanistic Pathways

Mitochondrial Electron Transport Chain

Mermaid diagram (expand to render)

Neurodegeneration Pathways

Mitochondrial dysfunction triggers multiple downstream effects:

Oxidative stress — ROS accumulation damages proteins, lipids, DNA

Energy failure — ATP depletion impairs cellular processes

Apoptosis — Mitochondrial outer membrane permeabilization

Calcium dysregulation — Impaired calcium buffering

Inflammation — Mitochondrial DAMPs trigger immune responses

Therapeutic Targeting

Strategies for Mitochondrial Protection

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Gene therapy | Deliver functional COA5 | Preclinical |
| Small molecules | Enhance complex IV assembly | Investigational |
| Antioxidants | Reduce oxidative stress | Various stages |
| Metabolic support | Improve energy metabolism | Clinical trials |

Current Research Directions

Developing AAV vectors for COA5 delivery
Screening for small molecule assembly factor enhancers
Combining mitochondrial support with other neuroprotective strategies

Animal Models

Knockout Models

COA5 knockout in model systems leads to:

Severe mitochondrial dysfunction
Reduced complex IV activity
Developmental abnormalities
Survival defects

Disease Models

Mitochondrial complex IV deficiency models replicate key features:

Lactic acidosis
Neurological dysfunction
Tissue-specific pathology

Key Publications

[Cerqua C, et al. Cytochrome c oxidase assembly factor 5 (COA5) is required for complex IV assembly and mitochondrial function. Hum Mol Genet (2015)](https://doi.org/10.1093/hmg/ddv073) — COA5 function in complex IV assembly.

[Indekeu E, et al. Mutations in COA5 cause severe mitochondrial encephalopathy with lactic acidosis. Brain (2012)](https://pubmed.ncbi.nlm.nih.gov/22984156/) — Clinical phenotype.

[Piru L, et al. Cytochrome c oxidase assembly factor COA5 is required for assembly of complex IV subunit. Mitochondrion (2014)](https://pubmed.ncbi.nlm.nih.gov/24726338/) — Assembly mechanism.

[Tim M, et al. Mitochondrial complex IV deficiency due to COA5 mutations: clinical spectrum and genetic basis. J Med Genet (2013)](https://pubmed.ncbi.nlm.nih.gov/23665960/) — Genetic basis.

[Saraste M, et al. Cytochrome c oxidase: a perspective on the role of assembly factors in disease. J Inherit Metab Dis (2015)](https://pubmed.ncbi.nlm.nih.gov/25846756/) — Assembly factors review.

[Szklarczyk R, et al. Cytochrome c oxidase biogenesis and neurodegenerative disease. Biochim Biophys Acta (2013)](https://pubmed.ncbi.nlm.nih.gov/23246573/) — Neurodegeneration link.

[Chouchani ET, et al. Mitochondrial dysfunction in neurodegeneration: the role of exercise and dietary interventions. Nat Rev Neurosci (2014)](https://pubmed.ncbi.nlm.nih.gov/24530245/) — Therapeutic approaches.

[Lin MT, et al. Mitochondrial DNA mutations and oxidative stress in neurodegenerative diseases. Nat Rev Neurol (2016)](https://pubmed.ncbi.nlm.nih.gov/27029942/) — mtDNA and neurodegeneration.

[Bhat AH, et al. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Neurochem Int (2012)](https://pubmed.ncbi.nlm.nih.gov/22023988/) — PD mechanisms.

[Schapira AH, et al. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (2012)](https://pubmed.ncbi.nlm.nih.gov/22300658/) — PD mitochondrial defects.

Cross-References

[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[ALS (Amyotrophic Lateral Sclerosis](/diseases/als)
[Mitochondrial Complex IV](/entities/mitochondrial-complex-iv)
[Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction-pd)
[Substantia Nigra](/brain-regions/substantia-nigra)
[Electron Transport Chain](/entities/electron-transport-chain)
[Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration)

COA5 (Cytochrome C Oxidase Assembly Factor 5)

COA5 (Cytochrome C Oxidase Assembly Factor 5)

Introduction

COA5 (Cytochrome C Oxidase Assembly Factor 5)

Introduction

Gene Structure and Protein Architecture

Genomic Organization

Protein Structure

Function

Normal Cellular Function

Mitochondrial Complex IV Assembly

Role in Electron Transport Chain

Expression Pattern

Disease Associations

Mitochondrial Complex IV Deficiency

Parkinson's Disease

Alzheimer's Disease

Amyotrophic Lateral Sclerosis (ALS)

Broader Neurodegenerative Context

Mechanistic Pathways

Mitochondrial Electron Transport Chain

Neurodegeneration Pathways

Therapeutic Targeting

Strategies for Mitochondrial Protection

Current Research Directions

Animal Models

Knockout Models

Disease Models

Key Publications

Cross-References

See Also